BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 15606511)

  • 1. Comparative study of cutaneous leishmaniasis in human immunodeficiency virus (HIV)-infected patients and non-HIV-infected patients in French Guiana.
    Couppié P; Clyti E; Sobesky M; Bissuel F; Del Giudice P; Sainte-Marie D; Dedet JP; Carme B; Pradinaud R
    Br J Dermatol; 2004 Dec; 151(6):1165-71. PubMed ID: 15606511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unusual manifestations of tegumentary leishmaniasis in AIDS patients from the New World.
    Lindoso JA; Barbosa RN; Posada-Vergara MP; Duarte MI; Oyafuso LK; Amato VS; Goto H
    Br J Dermatol; 2009 Feb; 160(2):311-8. PubMed ID: 19187345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of clinical presentation on the efficacy of a short course of pentamidine in the treatment of cutaneous leishmaniasis in French Guiana.
    Nacher M; Carme B; Sainte Marie D; Couppié P; Clyti E; Guibert P; Pradinaud R
    Ann Trop Med Parasitol; 2001 Jun; 95(4):331-6. PubMed ID: 11454242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disseminated cutaneous leishmaniasis due to Leishmania guyanensis: case of a patient with 425 lesions.
    Couppié P; Clyti E; Sainte-Marie D; Dedet JP; Carme B; Pradinaud R
    Am J Trop Med Hyg; 2004 Nov; 71(5):558-60. PubMed ID: 15569784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmaniases and HIV/AIDS co-infections: review of common features and management experiences.
    Ali A
    Ethiop Med J; 2002 Apr; 40 Suppl 1():37-49. PubMed ID: 12802830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Disseminated cutaneous leishmaniasis revealing human immunodeficiency virus infection].
    Durand I; Beylot-Barry M; Weill FX; Doutre MS; Beylot C
    Ann Dermatol Venereol; 1998 Apr; 125(4):268-70. PubMed ID: 9747266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Visceral leishmaniasis: a comparative study of patients with and without human immunodeficiency virus infection].
    Reus S; Sánchez R; Portilla J; Boix V; Priego M; Merino E; Román F
    Enferm Infecc Microbiol Clin; 1999 Dec; 17(10):515-20. PubMed ID: 10650648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical use of polymerase chain reaction performed on peripheral blood and bone marrow samples for the diagnosis and monitoring of visceral leishmaniasis in HIV-infected and HIV-uninfected patients: a single-center, 8-year experience in Italy and review of the literature.
    Antinori S; Calattini S; Longhi E; Bestetti G; Piolini R; Magni C; Orlando G; Gramiccia M; Acquaviva V; Foschi A; Corvasce S; Colomba C; Titone L; Parravicini C; Cascio A; Corbellino M
    Clin Infect Dis; 2007 Jun; 44(12):1602-10. PubMed ID: 17516404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal leishmaniasis: description of case management approaches and analysis of risk factors for treatment failure in a cohort of 140 patients in Brazil.
    Amato VS; Tuon FF; Imamura R; Abegão de Camargo R; Duarte MI; Neto VA
    J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1026-34. PubMed ID: 19453817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tegumentary leishmaniasis as a manifestation of immune reconstitution inflammatory syndrome in 2 patients with AIDS.
    Posada-Vergara MP; Lindoso JA; Tolezano JE; Pereira-Chioccola VL; Silva MV; Goto H
    J Infect Dis; 2005 Nov; 192(10):1819-22. PubMed ID: 16235183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis.
    Goto H; Lindoso JA
    Expert Rev Anti Infect Ther; 2010 Apr; 8(4):419-33. PubMed ID: 20377337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentamidine as secondary prophylaxis for visceral leishmaniasis in the immunocompromised host: report of four cases.
    Patel TA; Lockwood DN
    Trop Med Int Health; 2009 Sep; 14(9):1064-70. PubMed ID: 19552658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous leishmaniasis associated with visceral leishmaniasis in a case of acquired immunodeficiency syndrome (AIDS).
    Pourahmad M; Hooshmand F; Rahiminejad M
    Int J Dermatol; 2009 Jan; 48(1):59-61. PubMed ID: 19126052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Raised tattoos in a human-immunodeficiency-virus-infected patient].
    García-Lázaro M; Villar C; Natera C; Rivero A
    Enferm Infecc Microbiol Clin; 2009 Dec; 27(10):602-4. PubMed ID: 19419796
    [No Abstract]   [Full Text] [Related]  

  • 15. [Leishmania (Viannia) braziliensis Vianna, 1911 in French Guiana. Clinical, therapeutic and epidemiological considerations in the ninth human diagnosed case].
    Raccurt CP; Pradinaud R; Couppie P; Moreau B; Pratlong F; Dedet JP; Cotellon P; Juminer B; Sainte-Marie D
    Bull Soc Pathol Exot; 1996; 89(5):341-4. PubMed ID: 9264733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum.
    Lachaud L; Bourgeois N; Plourde M; Leprohon P; Bastien P; Ouellette M
    Clin Infect Dis; 2009 Jan; 48(2):e16-22. PubMed ID: 19093811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Identification of Leishmania (V) guyanensis during recurrences of cutaneous leishmaniasis contracted in French Guyana].
    Larriviere-Chouc C; De Pina JJ; Faraut-Gambarelli F; Morillon M; Normand P
    Med Trop (Mars); 1996; 56(3):309. PubMed ID: 9026604
    [No Abstract]   [Full Text] [Related]  

  • 18. [Mucocutaneous leishmaniasis due to Leishmania guyanensis: a case report in an HIV-infected patient].
    Fourcade S; Huber FI; Blanchet D; Aznar C; Clyti E; Simon S; Sainte-Marie D; Carme B; Couppié P
    Med Trop (Mars); 2008 Oct; 68(5):533-6. PubMed ID: 19068990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mucocutaneous leishmaniasis in a HIV infected patient. Case report].
    Montenegro-Idrogo JJ; Montañez-Valverde RA; Chian C; Benites-Villafane C
    Rev Chilena Infectol; 2014 Oct; 31(5):610-4. PubMed ID: 25491462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the intramuscular route to administer pentamidine isethionate in Leishmania guyanensis cutaneous leishmaniasis increases the risk of treatment failure.
    Christen JR; Bourreau E; Demar M; Lightburn E; Couppié P; Ginouvès M; Prévot G; Gangneux JP; Savini H; de Laval F; Pommier de Santi V; Briolant S
    Travel Med Infect Dis; 2018; 24():31-36. PubMed ID: 29482012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.